Presentation is loading. Please wait.

Presentation is loading. Please wait.

Report On Nationwide Utilization of Extended Half-Life, Clotting Factor Concentrate Fitri Primacakti, MD.

Similar presentations


Presentation on theme: "Report On Nationwide Utilization of Extended Half-Life, Clotting Factor Concentrate Fitri Primacakti, MD."— Presentation transcript:

1 Report On Nationwide Utilization of Extended Half-Life, Clotting Factor Concentrate
Fitri Primacakti, MD

2 Drug Donation From WFH Start from 2005 - until now
Extended Half-Life (EHL), clotting factor concentrates, from 2015

3 1st shippment

4 2nd shippment

5 Extended Half-Life Drug Shippment
* Maret, 2016 * 2600 vials (Eloctate & Alprolix) 1st shippment * February, 2017 * 2900 vials (Eloctate & Alprolix) 2nd shippment

6 Clotting Factor Concentrate Utilization
Eloctate 1802 vials Alprolix 1215 vials

7 Eloctate Utilization 228 vials 244 vials 100 vials

8 Alprolix Utilization 730 vials 485 vials

9 Drug Distribution Aceh Medan Padang Manado Riau Banjarmasin Samarinda
Palembang Riau Manado Makassar Samarinda Banjarmasin Jakarta & Banten Bandung Yogya Malang & Surabaya Semarang, Solo Bali

10 Drug Distribution Borneo: 79.500 IU Sumatera: 33.000 IU
Sulawesi: IU Java & Bali: IU

11 Drug Distribution To Hemophilia Treatment Center
BORNEO SUMATERA Banjarmasin IU Samarinda IU Aceh IU Medan IU Padang IU Riau IU Palembang IU SULAWESI Manado IU Makassar IU JAVA & BALI Jakarta IU Bandung IU Semarang IU Yogyakarta IU Malang IU Surabaya IU Bali 6000 IU

12 Indication For EHL Donation Utilization
Inadequate supply of clotting factor concentrate (CFC) due to limited coverage by the insurance Major surgery Life-threatening bleeding (CNS, GI tract, throat & neck, opthalmic, renal & massive bleeding due to accident/trauma) Unavailability of clotting factor concentrate Others indication decided by HCPs in each region

13 Clotting Factor Donation Utilization

14 Clotting Factor Donation Utilization

15 Emergency & Life-Threathening Bleeding
Intracranial Iliopsoas Throat and Neck Genitourinary GI tract

16 Surgery Neurosurgery craniotomy for hemorrhage evacuation
Orthopedic synovectomy, bleed aspiration, arthroidesis, total knee replacement, ORIF Dental tooth extraction Urology circumcision DIgestive laparotomy exploration Throat & Neck coin lesion extraction

17 Inadequate Supply of Clotting Factor Concentrate
Joint bleeding Muscle bleeding Dental bleeding

18 Type Of Bleeding & Procedure

19 No adverse event were seen until now

20 Intracranial bleeding Hemorrhage evacuation
Hemophilia B Intracranial bleeding Hemorrhage evacuation

21 Hemophilia Arthropathy
Synovectomy

22 Wound laceration due to motorcycle accident
Hemophilia A Wound laceration due to motorcycle accident Surgery

23 Circumcision procedure
Hemophilia A Circumcision procedure

24 Thank You


Download ppt "Report On Nationwide Utilization of Extended Half-Life, Clotting Factor Concentrate Fitri Primacakti, MD."

Similar presentations


Ads by Google